For some reason I am very excited to read the reply from the management...
Happy that the trials are starting very soon...
Also the strategy move is interesting and exciting as obviously it has to be in the best interest in terms of adding value somewhere...
Small combo drug trial might be new program and obviously if they are thinking in that line means we have stellar results for Dystro levels..
Now if this is true by any chance then Sarepta and 2 others can either sit and watch us or move first and take the advantage ...once if someone moves the other 2 are sure to wake up and thats what we need ...some competition which will make more value for our drug...
This truly feels very very undervalued here around these levels ...and as George says we will say why didn't we buy more?
I am looking to adding more to my position in the next few days....just a little confidence i have got with the mgt reply...
